Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.
第一作者:
David W,Vaughn
第一单位:
a GlaxoSmithKline Vaccines ; Rixensart , Belgium.
作者:
关键词
AECenter for Biologics Evaluation and Research; CHMPCommittee for Medicinal Products for Human Use; MedDRAGood Clinical Practice; CBERMedical Dictionary for Regulatory Activities; PTadverse event of special interest; MAEadverse event; pIMDconfidence interval; RRincidence rate; GCPmedically-attended adverse event; SAEnew onset chronic disease; CIpotential immune-mediated disease; AESIpreferred termrelative risk; SDsafety, potential immune-mediated disease, A(H1N1)pdm09 vaccine, H5N1 vaccine, influenza A(H5N1), pandemic influenza A(H1N1), pooled analysisserious adverse event; NOCDstandard deviation; IR
医学主题词
佐剂, 免疫(Adjuvants, Immunologic);青少年(Adolescent);成年人(Adult);抗体, 病毒(Antibodies, Viral);复方合剂(Drug Combinations);女(雌)性(Female);人类(Humans);流感病毒A型, H1N1亚型(Influenza A Virus, H1N1 Subtype);流感病毒A型, H5N1亚型(Influenza A Virus, H5N1 Subtype);流感疫苗(Influenza Vaccines);流感, 人(Influenza, Human);男(雄)性(Male);中年人(Middle Aged);聚山梨醇酯类(Polysorbates);危险(Risk);角鲨烯(Squalene);接种(Vaccination);青年人(Young Adult);α生育酚(alpha-Tocopherol)
DOI
10.4161/21645515.2014.972149
PMID
25483467
发布时间
2024-03-26
- 浏览147
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



